BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Biodexa Pharmaceuticals Plc
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$0.39−0.07 (-14.36%)
Close on Oct 19, 2026
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Apr 6, 2026 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Jul 31, 2025 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Oct 4, 2024 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Jul 5, 2023 | 1-for-80 reverse | Earlier per-share figures multiplied by 80 |
| Apr 28, 2023(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Mar 27, 2023 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Sep 26, 2022 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Jun 15, 2020(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Mar 3, 2020 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Apr 8, 2019 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |